The global biohacking market size is anticipated to reach USD 63.7 billion by 2028, registering a CAGR of 19.4% over the forecast period, according to a new report by Grand View Research, Inc. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due to their potential applications in decreasing the risk of developing a disease, especially genetically associated diseases, helping an individual to achieve mental, physical, or emotional changes, such as weight loss or reducing depression symptoms; and optimize general functions of the body, such as blood pressure.
The global market has been significantly affected by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. However, biohackers in the industry are investing in some research activities for the development of COVID-19 vaccines as well as test kits. This neutralized the market growth in 2020. For the purchase of equipment and materials, biohackers require basic funding. Other than crowdfunding, most of the activities at these labs are self-funded through membership and workshop fees. Furthermore, private donations are also used for raising money.
Oura Health, manufacturer of the Oura ring, a sleep-improvement and sleep tracking platform, raised USD 20 million in Series B funding led by MSD Capital in December 2018. The global market is fairly competitive. Most of the market players have undertaken strategies, such as new product launches, acquisitions, and partnerships, to gain a competitive edge over each other. For instance, in September 2020, Apple Inc. partnered with the government of Singapore for launching a national health initiative using Apple Watch. With this, the country made an effort to leverage technology for delivering advanced health benefits to its citizens.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/biohacking-market
Biohacking Market Report Highlights
- The wearables segment held the largest revenue share in 2020 owing to the high demand for wearables across the globe
- The monitoring application segment led the market with a revenue share of more than 28.17% in 2020 owing to high product adoption for monitoring patient health conditions
- The forensic laboratories segment is expected to register the second-fastest CAGR from 2021 to 2028 owing to the rising application of biohacking practices in forensic laboratories
- In 2020, North America held the dominant share of the overall revenue owing to the presence of several key market players in the region, especially in the U.S.
- Europe held the second-largest revenue share in 2020 and will expand at a steady CAGR from 2021 to 2028
- Asia Pacific is expected to record the fastest CAGR over the forecast period owing to the presence of technologically advanced healthcare infrastructure along with favorable government initiatives
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/biohacking-market/request/rs1
Biohacking Market Segmentation
Grand View Research has segmented the global biohacking market on the basis of the product, application, end user, and region:
Biohacking Product Outlook (Revenue, USD Million, 2016 – 2028)
- Wearables
- Implants (Chips)
- Gene Modification Kits
- Smart Drugs
- Supplements
- Mobile Apps
- Others
Biohacking Application Outlook (Revenue, USD Million, 2016 – 2028)
- Monitoring
- Treatment
- Research
- Others
Biohacking End-user Outlook (Revenue, USD Million, 2016 – 2028)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Forensic Laboratories
- Research & Academic Institutes
- Others
Biohacking Regional Outlook (Revenue, USD Million, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Asia Pacific
- Japan
- South Korea
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
List of Key Players of Biohacking Market
- Apple, Inc.
- The ODIN
- Thync Global, Inc.
- Fitbit, Inc.
- Moodmetric
- HVMN, Inc.
- Muse (Interaxon, Inc.)
- Thriveport, LLC
- TrackMyStack
- OsteoStrong
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/450713/ibb
About Grand View Research
Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide.
Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/biohacking-market